UDP-4-Keto-6-Deoxyglucose, a Transient Antifungal Metabolite, Weakens the Fungal Cell Wall Partly by Inhibition of UDP-Galactopyranose Mutase

ABSTRACT Can accumulation of a normally transient metabolite affect fungal biology? UDP-4-keto-6-deoxyglucose (UDP-KDG) represents an intermediate stage in conversion of UDP-glucose to UDP-rhamnose. Normally, UDP-KDG is not detected in living cells, because it is quickly converted to UDP-rhamnose by...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Liang Ma, Omar Salas, Kyle Bowler, Maor Bar-Peled, Amir Sharon
Formato:	article
Lenguaje:	EN
Publicado:	American Society for Microbiology 2017
Materias:	Botrytis cinerea UDP-4-keto-6-deoxyglucose UDP-galactopyranose mutase fungal cell wall fungal nucleotide sugar metabolism galactofuranose Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/64f60381e6044febbf061053744506f0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:64f60381e6044febbf061053744506f0
record_format	dspace
spelling	oai:doaj.org-article:64f60381e6044febbf061053744506f02021-11-15T15:51:55ZUDP-4-Keto-6-Deoxyglucose, a Transient Antifungal Metabolite, Weakens the Fungal Cell Wall Partly by Inhibition of UDP-Galactopyranose Mutase10.1128/mBio.01559-172150-7511https://doaj.org/article/64f60381e6044febbf061053744506f02017-12-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01559-17https://doaj.org/toc/2150-7511ABSTRACT Can accumulation of a normally transient metabolite affect fungal biology? UDP-4-keto-6-deoxyglucose (UDP-KDG) represents an intermediate stage in conversion of UDP-glucose to UDP-rhamnose. Normally, UDP-KDG is not detected in living cells, because it is quickly converted to UDP-rhamnose by the enzyme UDP-4-keto-6-deoxyglucose-3,5-epimerase/-4-reductase (ER). We previously found that deletion of the er gene in Botrytis cinerea resulted in accumulation of UDP-KDG to levels that were toxic to the fungus due to destabilization of the cell wall. Here we show that these negative effects are at least partly due to inhibition by UDP-KDG of the enzyme UDP-galactopyranose mutase (UGM), which reversibly converts UDP-galactopyranose (UDP-Galp) to UDP-galactofuranose (UDP-Galf). An enzymatic activity assay showed that UDP-KDG inhibits the B. cinerea UGM enzyme with a Ki of 221.9 µM. Deletion of the ugm gene resulted in strains with weakened cell walls and phenotypes that were similar to those of the er deletion strain, which accumulates UDP-KDG. Galf residue levels were completely abolished in the Δugm strain and reduced in the Δer strain, while overexpression of the ugm gene in the background of a Δer strain restored Galf levels and alleviated the phenotypes. Collectively, our results show that the antifungal activity of UDP-KDG is due to inhibition of UGM and possibly other nucleotide sugar-modifying enzymes and that the rhamnose metabolic pathway serves as a shunt that prevents accumulation of UDP-KDG to toxic levels. These findings, together with the fact that there is no Galf in mammals, support the possibility of developing UDP-KDG or its derivatives as antifungal drugs. IMPORTANCE Nucleotide sugars are donors for the sugars in fungal wall polymers. We showed that production of the minor sugar rhamnose is used primarily to neutralize the toxic intermediate compound UDP-KDG. This surprising finding highlights a completely new role for minor sugars and other secondary metabolites with undetermined function. Furthermore, the toxic potential of predicted transition metabolites that never accumulate in cells under natural conditions are highlighted. We demonstrate that UDP-KDG inhibits the UDP-galactopyranose mutase enzyme, thereby affecting production of Galf, which is one of the components of cell wall glycans. Given the structural similarity, UDP-KDG likely inhibits additional nucleotide sugar-utilizing enzymes, a hypothesis that is also supported by our findings. Our results suggest that UDP-KDG could serve as a template to develop antifungal drugs.Liang MaOmar SalasKyle BowlerMaor Bar-PeledAmir SharonAmerican Society for MicrobiologyarticleBotrytis cinereaUDP-4-keto-6-deoxyglucoseUDP-galactopyranose mutasefungal cell wallfungal nucleotide sugar metabolismgalactofuranoseMicrobiologyQR1-502ENmBio, Vol 8, Iss 6 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Botrytis cinerea UDP-4-keto-6-deoxyglucose UDP-galactopyranose mutase fungal cell wall fungal nucleotide sugar metabolism galactofuranose Microbiology QR1-502
spellingShingle	Botrytis cinerea UDP-4-keto-6-deoxyglucose UDP-galactopyranose mutase fungal cell wall fungal nucleotide sugar metabolism galactofuranose Microbiology QR1-502 Liang Ma Omar Salas Kyle Bowler Maor Bar-Peled Amir Sharon UDP-4-Keto-6-Deoxyglucose, a Transient Antifungal Metabolite, Weakens the Fungal Cell Wall Partly by Inhibition of UDP-Galactopyranose Mutase
description	ABSTRACT Can accumulation of a normally transient metabolite affect fungal biology? UDP-4-keto-6-deoxyglucose (UDP-KDG) represents an intermediate stage in conversion of UDP-glucose to UDP-rhamnose. Normally, UDP-KDG is not detected in living cells, because it is quickly converted to UDP-rhamnose by the enzyme UDP-4-keto-6-deoxyglucose-3,5-epimerase/-4-reductase (ER). We previously found that deletion of the er gene in Botrytis cinerea resulted in accumulation of UDP-KDG to levels that were toxic to the fungus due to destabilization of the cell wall. Here we show that these negative effects are at least partly due to inhibition by UDP-KDG of the enzyme UDP-galactopyranose mutase (UGM), which reversibly converts UDP-galactopyranose (UDP-Galp) to UDP-galactofuranose (UDP-Galf). An enzymatic activity assay showed that UDP-KDG inhibits the B. cinerea UGM enzyme with a Ki of 221.9 µM. Deletion of the ugm gene resulted in strains with weakened cell walls and phenotypes that were similar to those of the er deletion strain, which accumulates UDP-KDG. Galf residue levels were completely abolished in the Δugm strain and reduced in the Δer strain, while overexpression of the ugm gene in the background of a Δer strain restored Galf levels and alleviated the phenotypes. Collectively, our results show that the antifungal activity of UDP-KDG is due to inhibition of UGM and possibly other nucleotide sugar-modifying enzymes and that the rhamnose metabolic pathway serves as a shunt that prevents accumulation of UDP-KDG to toxic levels. These findings, together with the fact that there is no Galf in mammals, support the possibility of developing UDP-KDG or its derivatives as antifungal drugs. IMPORTANCE Nucleotide sugars are donors for the sugars in fungal wall polymers. We showed that production of the minor sugar rhamnose is used primarily to neutralize the toxic intermediate compound UDP-KDG. This surprising finding highlights a completely new role for minor sugars and other secondary metabolites with undetermined function. Furthermore, the toxic potential of predicted transition metabolites that never accumulate in cells under natural conditions are highlighted. We demonstrate that UDP-KDG inhibits the UDP-galactopyranose mutase enzyme, thereby affecting production of Galf, which is one of the components of cell wall glycans. Given the structural similarity, UDP-KDG likely inhibits additional nucleotide sugar-utilizing enzymes, a hypothesis that is also supported by our findings. Our results suggest that UDP-KDG could serve as a template to develop antifungal drugs.
format	article
author	Liang Ma Omar Salas Kyle Bowler Maor Bar-Peled Amir Sharon
author_facet	Liang Ma Omar Salas Kyle Bowler Maor Bar-Peled Amir Sharon
author_sort	Liang Ma
title	UDP-4-Keto-6-Deoxyglucose, a Transient Antifungal Metabolite, Weakens the Fungal Cell Wall Partly by Inhibition of UDP-Galactopyranose Mutase
title_short	UDP-4-Keto-6-Deoxyglucose, a Transient Antifungal Metabolite, Weakens the Fungal Cell Wall Partly by Inhibition of UDP-Galactopyranose Mutase
title_full	UDP-4-Keto-6-Deoxyglucose, a Transient Antifungal Metabolite, Weakens the Fungal Cell Wall Partly by Inhibition of UDP-Galactopyranose Mutase
title_fullStr	UDP-4-Keto-6-Deoxyglucose, a Transient Antifungal Metabolite, Weakens the Fungal Cell Wall Partly by Inhibition of UDP-Galactopyranose Mutase
title_full_unstemmed	UDP-4-Keto-6-Deoxyglucose, a Transient Antifungal Metabolite, Weakens the Fungal Cell Wall Partly by Inhibition of UDP-Galactopyranose Mutase
title_sort	udp-4-keto-6-deoxyglucose, a transient antifungal metabolite, weakens the fungal cell wall partly by inhibition of udp-galactopyranose mutase
publisher	American Society for Microbiology
publishDate	2017
url	https://doaj.org/article/64f60381e6044febbf061053744506f0
work_keys_str_mv	AT liangma udp4keto6deoxyglucoseatransientantifungalmetaboliteweakensthefungalcellwallpartlybyinhibitionofudpgalactopyranosemutase AT omarsalas udp4keto6deoxyglucoseatransientantifungalmetaboliteweakensthefungalcellwallpartlybyinhibitionofudpgalactopyranosemutase AT kylebowler udp4keto6deoxyglucoseatransientantifungalmetaboliteweakensthefungalcellwallpartlybyinhibitionofudpgalactopyranosemutase AT maorbarpeled udp4keto6deoxyglucoseatransientantifungalmetaboliteweakensthefungalcellwallpartlybyinhibitionofudpgalactopyranosemutase AT amirsharon udp4keto6deoxyglucoseatransientantifungalmetaboliteweakensthefungalcellwallpartlybyinhibitionofudpgalactopyranosemutase
_version_	1718427339651547136

UDP-4-Keto-6-Deoxyglucose, a Transient Antifungal Metabolite, Weakens the Fungal Cell Wall Partly by Inhibition of UDP-Galactopyranose Mutase

Ejemplares similares